T-cell count and T-cell telomere length in patients with severe COVID-19

被引:0
|
作者
Kraft, Bryan D. [1 ]
Verhulst, Simon [2 ]
Lai, Tsung-Po [3 ]
Sullenger, Bruce A. [4 ]
Wang, Yunfei [5 ]
Rountree, Wes [5 ]
Chen, Lingye [1 ]
Woods, Christopher W. [6 ,7 ]
Denny, Thomas N. [5 ]
Aviv, Abraham [3 ,8 ]
机构
[1] Duke Univ, Med Ctr, Div Pulm Allergy & Crit Care Med, Durham, NC 27708 USA
[2] Univ Groningen, Groningen Inst Evolutionary Life Sci, Groningen, Netherlands
[3] Rutgers State Univ, Ctr Human Dev & Aging, New Jersey Med Sch, Newark, NJ USA
[4] Duke Univ, Dept Surg, Med Ctr, Durham, NC USA
[5] Duke Human Vaccine Inst, Durham, NC USA
[6] Duke Univ, Ctr Infect Dis & Diagnost Innovat, Med Ctr, Durham, NC USA
[7] Durham Vet Affairs Hlth Care Syst, Pharm Dept, Durham, NC USA
[8] Rutgers State Univ, New Jersey Med Sch, Dept Pediat, Newark, NJ USA
来源
FRONTIERS IN IMMUNOLOGY | 2024年 / 15卷
基金
美国国家卫生研究院;
关键词
SARS-CoV-2; COVID-19; T-lymphocytes; lymphopenia; sex; aging; telomere;
D O I
10.3389/fimmu.2024.1356638
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Lymphocyte telomere length (TL) is highly variable and shortens with age. Short telomeres may impede TL-dependent T-cell clonal expansion with viral infection. As SARS-CoV-2 infection can induce prolonged and severe T-cell lymphopenia, infected adults, and particularly older adults with short telomeres, may display severe T-cell lymphopenia. To examine the relationship between T-cell TL parameters and T-cell counts, we studied 40 patients hospitalized with severe COVID-19. T-cells were isolated from lymphocytes, counted using flow cytometry, and their TL parameters were measured using the Telomere Shortest Length Assay. The cohort (median age = 62 years, 27% female) was racially and ethnically diverse (33% White, 35% Black, and 33% Other). On intensive care unit study day 1, T-cell count (mean=1.03 x109/L) was inversely related to age (p=0.007) and higher in females than males (p=0.025). Mean TL was 3.88 kilobases (kb), and 45.3% of telomeres were shorter than 3 kb. Using multiple regression analysis and adjusting for age and sex, T-cell count decreased with increased proportion of T-cell telomeres shorter than 3 kb (p=0.033) and increased with mean TL (p=0.052). Our findings suggest an association between the buildup of short telomeres within T-cells and explain in part reduced peripheral blood T-cell counts in patients with severe COVID-19. Shortened T-cell telomeres may be a risk factor for COVID-19-associated T-cell lymphopenia.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Potential mechanisms by which impaired ketogenesis links metabolism to T-cell dysfunction in patients with severe COVID-19
    Wang, Bin
    Zhang, Lei
    Zhou, Fangfang
    Zhang, Long
    MEDCOMM, 2022, 3 (04):
  • [22] T-cell immune dysfunction of severe COVID-19 in asthma defined by single-cell RNA sequencing
    Kim, Youlim
    Cho, Mira
    Lee, Hyun
    Lee, Sang Hoon
    Lee, Siyoung
    Choi, Minjun
    Lee, Byeongchan
    Lim, Seong Yong
    Yoo, Kwang Ha
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [23] Targeting T-cell senescence and cytokine storm with rapamycin to prevent severe progression in COVID-19
    Omarjee, Loukman
    Janin, Anne
    Perrot, Frederique
    Laviolle, Bruno
    Meilhac, Olivier
    Mahe, Guillaume
    CLINICAL IMMUNOLOGY, 2020, 216
  • [24] Adoptive T-cell therapies to overcome T cell-dependent immune dysregulations in COVID-19
    Kalkanli Tas, Sevgi
    Uzunoglu, Merve Saide
    Uzunoglu, Aylin Seher
    Kirkik, Duygu
    Altunkanat, Derya
    Kalkanli, Nevin
    TURKISH JOURNAL OF BIOLOGY, 2022, 46 (02) : 105 - 117
  • [25] Humoral and T-cell responses to COVID-19 vaccination in patients with inflammatory bowel disease
    Zhang, E.
    Bond, K.
    Nguyen, O.
    Rowntree, L.
    Allen, L.
    Kedzierka, K.
    Christensen, B.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 : 119 - 120
  • [26] COVID-19 outcomes among patients with cutaneous T-cell lymphoma: A multicentered analysis
    Baker, Mairead
    Pakhchanian, Haig
    Raiker, Rahul
    Deng, Min
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB153 - AB153
  • [27] PRE-CLINICAL DEVELOPMENT OF T-CELL IMMUNOTHERAPY FOR COVID-19
    Smith, C.
    Panikkar, A.
    Raju, J.
    Rehan, S.
    Lineburg, K.
    Crooks, P.
    Thomas, G. Ambalathingal
    Swaminathan, S.
    Khanna, R.
    Matthews, K.
    Neller, M.
    CYTOTHERAPY, 2021, 23 (05) : S108 - S108
  • [28] Cutaneous T-cell lymphoma (CTCL) outcomes during COVID-19
    Garcia-Saleem, Tiffany J.
    Stonesifer, Connor J.
    Geskin, Larisa J.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB203 - AB203
  • [29] The characterization of CD8+ T-cell responses in COVID-19
    Yang, Yuanting
    Miller, Heather
    Byazrova, Maria G.
    Cndotti, Fabio
    Benlagha, Kamel
    Camara, Niels Olsen Saraiva
    Shi, Junming
    Forsman, Huamei
    Lee, Pamela
    Yang, Lu
    Filatov, Alexander
    Zhai, Zhimin
    Liu, Chaohong
    EMERGING MICROBES & INFECTIONS, 2024, 13 (01)
  • [30] Early immunomodulators with CAR T-cell immunotherapy in the COVID-19 era
    Abid, Muhammad Bilal
    LANCET ONCOLOGY, 2022, 23 (01): : 16 - 18